Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Loqtorzi
Descriptions
Toripalimab-tpzi injection is used in combination with cisplatin and gemcitabine as first-line treatment of nasopharyngeal carcinoma (nose and throat cancer) that has spread throughout the body (metastatic) or has returned. It is also used alone to treat nasopharyngeal carcinoma in patients who have received other cancer medicines (eg, platinum) that did not work well, or whose cancer has returned, cannot be removed by surgery, or has spread.
Toripalimab-tpzi is a monoclonal antibody that changes the immune system to help control the growth of cancer cells.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.